Related Experiment Video
Updated: Jun 21, 2026
07:13
Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
Published on: January 7, 2019
The arachidonic acid effect on platelet nitric oxide level.
Maria Grazia Signorello1, Alessia Segantin, Giuliana Leoncini
1Department of Experimental Medicine, Biochemistry Section, University of Genoa, Viale Benedetto XV 1, 16132 Genova, Italy.
Biochimica Et Biophysica Acta
|July 21, 2009
Summary
Arachidonic acid decreases platelet nitric oxide (NO) levels by activating protein kinase C (PKC) and NADPH oxidase, potentially increasing platelet aggregation. This study uncovers key molecular mechanisms behind this effect.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Arachidonic acid is a crucial second messenger involved in numerous cellular functions.
- Platelet nitric oxide (NO) plays a vital role in regulating platelet activity and vascular homeostasis.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying arachidonic acid's impact on platelet nitric oxide (NO) levels.
- To investigate the role of protein kinase C (PKC) and NADPH oxidase in mediating arachidonic acid's effects on NO bioavailability.
Main Methods:
- Quantification of nitric oxide (NO), cyclic guanosine monophosphate (cGMP), and superoxide anion levels.
- Assessment of nitric oxide synthase (eNOS) phosphorylation status.
- Measurement of protein kinase C (PKC) and NADPH oxidase activation using specific inhibitors and activators.
Main Results:
- Arachidonic acid dose-dependently reduced platelet NO and cGMP levels, mimicking the effect of thromboxane A(2) mimetic U46619.
- These effects were mediated via thromboxane A(2) receptor, protein kinase C (PKC), and phospholipase C pathways.
- Arachidonic acid increased eNOS phosphorylation at the inhibitory Thr495 residue, activated PKC and NADPH oxidase, leading to superoxide anion formation, thereby reducing NO bioavailability.
Conclusions:
- Arachidonic acid reduces nitric oxide (NO) bioavailability in platelets through activation of PKC and NADPH oxidase pathways.
- The observed decrease in NO levels may enhance platelet aggregation, contributing to thrombotic processes.
- Understanding these mechanisms provides insights into platelet function and potential therapeutic targets.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...